Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × IDH Mutation in glioblastoma Molecular Biomarkers of GliomaRole of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade GliomaPrognostic significance of PD-L1 and CD45RO(+) cells in glioblastoma: The modulating role of MMR statusClinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a "molecular" glioblastomaQuantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype GlioblastomaDiagnostic Utility of Intratumoral Susceptibility Signals in Adult Diffuse Gliomas: Tumor Grade Prediction and Correlation with Molecular Markers Within the WHO CNS5 (2021) ClassificationATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospitalMethionine PET Findings in the Diagnosis of Brain Tumors and Non-Tumorous Mass Lesions: A Single-Center Report on 426 Cases idh_mutation_in_glioblastoma.txt Last modified: 2024/06/07 02:55by 127.0.0.1